These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21221877)

  • 1. Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.
    Li QL; Yang ZL; Liu JQ; Miao XY
    Pathol Oncol Res; 2011 Sep; 17(3):561-8. PubMed ID: 21221877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Deng X; Wen Y; Yang Z; Miao X
    World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.
    Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X
    World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
    Yang L; Lan S; Liu J; Yang Z
    Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Lv F; Yang ZL; Miao XY
    Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
    Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
    Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
    Yuan LW; Liu DC; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
    Li Q; Yang Z
    J Exp Clin Cancer Res; 2009 May; 28(1):65. PubMed ID: 19445727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
    Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
    Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
    Liu DC; Yang ZL
    Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.
    Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J
    Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder].
    Yang LP; Yang ZL; Tan XG; Miao XY
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):595-9. PubMed ID: 21122411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
    Liu DC; Yang ZL
    Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
    Liu DC; Yang ZL; Jiang S
    Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance.
    Chen Y; Chen C; Ma C; Sun S; Zhang J; Sun Y
    Int J Clin Exp Pathol; 2015; 8(2):1946-53. PubMed ID: 25973087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.
    Yang Z; Liu F; Yang ZL
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):275-82. PubMed ID: 26200836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.